Insight Wealth Strategies, LLC Gilead Sciences, Inc. Transaction History

Insight Wealth Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$73.27 - $83.09 $70,485 - $79,932	962 Added 4.1%	24,412 $1.98 Million
Q3 2023 Oct 13, 2023	BUY	$73.94 - $80.67 $142,778 - $155,773	1,931 Added 8.97%	23,450 $1.76 Million
Q2 2023 Jul 14, 2023	SELL	$76.01 - $86.7 $36,712 - $41,876	-483 Reduced 2.2%	21,519 $1.66 Million
Q1 2023 Apr 06, 2023	SELL	$77.31 - $88.08 $271,667 - $309,513	-3,514 Reduced 13.77%	22,002 $1.83 Million
Q4 2022 Jan 06, 2023	BUY	$62.32 - $89.47 $41,193 - $59,139	661 Added 2.66%	25,516 $0
Q2 2022 Jul 01, 2022	BUY	$57.72 - $65.01 $1.43 Million - $1.62 Million	24,855 New	24,855 $1.54 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Insight Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Insight Wealth Strategies, LLC with notifications on news.